A multi-centre phase I trial of the PARP inhibitor olaparib in patients with relapsed chronic lymphocytic leukaemia, T-prolymphocytic leukaemia or mantle cell lymphoma.
作者信息
Pratt Guy, Yap Christina, Oldreive Ceri, Slade Daniel, Bishop Rebecca, Griffiths Mike, Dyer Martin J S, Fegan Chris, Oscier David, Pettitt Andrew, Matutes Estella, Devereux Stephen, Allsup David, Bloor Adrian, Hillmen Peter, Follows George, Rule Simon, Moss Paul, Stankovic Tatjana
机构信息
University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK.
出版信息
Br J Haematol. 2018 Aug;182(3):429-433. doi: 10.1111/bjh.14793. Epub 2017 Jun 23.
PMID:28643365
Abstract
摘要
Zotero 插件